These recommendations provide a data-supported approach. They are based on the
following:(1) formal review and analysis of the recently published world literature on the topic (…

Nonalcoholic steatohepatitis, along with other forms of nonalcoholic fatty liver disease, is a
chronic liver disease that is attracting increasing significance. It is a clinicopathologic …

Nonalcoholic fatty liver disease occurs most frequently in obese middle-aged women. It also
may occur, however, in children and normal-weight men with normal glucose and lipid …

Background Nonalcoholic steatohepatitis is a common liver disease that can progress to
cirrhosis. Currently, there is no established treatment for this disease. Methods We randomly …

BACKGROUND AND PURPOSE: Nonalcoholic fatty liver disease is frequently associated
with type 2 diabetes mellitus, obesity, and dyslipidemia, but some patients have normal …

Nonalcoholic fatty liver disease is a common cause of chronic liver disease in the general
population. Nonalcoholic steatohepatitis (NASH), the aggressive form of nonalcoholic fatty …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
United States, and its prevalence is increasing worldwide. It currently affects approximately 30…

BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) encompasses a wide
spectrum of conditions ranging from simple hepatic steatosis to nonalcoholic steatohepatitis (…

The Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) was formed to
conduct multicenter studies on the etiology, contributing factors, natural history, and treatment …

Background & Aims: Nonalcoholic fatty liver disease (NAFLD) is reported commonly in
patients with type 2 diabetes mellitus (DM), which has been suggested as a risk factor for the …